328 related articles for article (PubMed ID: 26379151)
1. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
[TBL] [Abstract][Full Text] [Related]
2. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with
Luchtel RA; Dasari S; Oishi N; Pedersen MB; Hu G; Rech KL; Ketterling RP; Sidhu J; Wang X; Katoh R; Dogan A; Kip NS; Cunningham JM; Sun Z; Baheti S; Porcher JC; Said JW; Jiang L; Hamilton-Dutoit SJ; Møller MB; Nørgaard P; Bennani NN; Chng WJ; Huang G; Link BK; Facchetti F; Cerhan JR; d'Amore F; Ansell SM; Feldman AL
Blood; 2018 Sep; 132(13):1386-1398. PubMed ID: 30093402
[TBL] [Abstract][Full Text] [Related]
4. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
[TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
Xing X; Flotte TJ; Law ME; Blahnik AJ; Chng WJ; Huang G; Knudson RA; Ketterling RP; Porcher JC; Ansell SM; Sidhu J; Dogan A; Feldman AL
Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):580-9. PubMed ID: 25390351
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
Fadl A; Oishi N; Shi M; Dasari S; Ansell SM; Ketterling RP; Feldman AL
Hum Pathol; 2023 Nov; 141():6-14. PubMed ID: 37633531
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
Magaki S; Satyadev R; Chen Z; Yung KS; Vinters HV; Kinney MC; Said JW
Brain Tumor Pathol; 2022 Jan; 39(1):25-34. PubMed ID: 34791573
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma.
Feldman AL; Oishi N; Ketterling RP; Ansell SM; Shi M; Dasari S
Am J Surg Pathol; 2022 Nov; 46(11):1490-1499. PubMed ID: 35941721
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity.
Wang JC; Zhong LH; Lin WQ; Zhang WF; Xi YF; Liu YP; Zhu Q; Liu W; Zhu WF; Chen YP; Chen G
Am J Surg Pathol; 2023 Jan; 47(1):55-64. PubMed ID: 36315833
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
[No Abstract] [Full Text] [Related]
13. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
Wang C; Chen X; Chen XY; He YH
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
[No Abstract] [Full Text] [Related]
14. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
15.
Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
[TBL] [Abstract][Full Text] [Related]
16. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
Feldman AL; Dogan A; Smith DI; Law ME; Ansell SM; Johnson SH; Porcher JC; Ozsan N; Wieben ED; Eckloff BW; Vasmatzis G
Blood; 2011 Jan; 117(3):915-9. PubMed ID: 21030553
[TBL] [Abstract][Full Text] [Related]
17. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
18. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Boddicker RL; Feldman AL
Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
[No Abstract] [Full Text] [Related]
19. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B; Cairoli A; Gaide O; Somja J; Bregnard C; Gaulard P; Xerri L; Lefort K; Missiaglia E; Gilliet M; Hohl D; Guenova E; de Leval L
Virchows Arch; 2022 Oct; 481(4):653-657. PubMed ID: 35366115
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]